Dr. med. Thomas F. Schulz Klinik / Institut: Institut für Virologie, MHH Wir wollen breit neutralisierende, d.h. gegen verschiedene Coronaviren schützende, humane monoklonale Antikörper als rekombinante [...] idaten gegen SARS-CoV-2 Projektleitung: Prof. Dr. Reinhold Förster Klinik / Institut: Institut für Immunologie Das Institut für Immunologie testet in Kooperation mit der Ludwig-Maximilians-Universität [...] Interface cultures of human primary distal respiratory epithelial for in vitro modelling of SARS-CoV2 infection Projektleitung: Prof. Ulrich Martin, Dr. Ruth Olmer Klinik / Institut: HTTG/ LEBAO Eine Infektion
therapy. Final exam June 2020. Michelangelo Marasco ITALY Supervisor: Prof. Dr. Teresa Carlomagno, Institute for Organic Chemistry / BMWZ, Leibniz Universität Hannover, Project: Structural basis of the activation [...] : Prof. Dr. Christine Falk, IFB-Tx, OE 8889, Project: T and NK cell-mediated immune responses of human lung transplant recipients in vivo - impact on the development of transplant arteriosclerosis. Final [...] Dr. Hildegard Büning, Experimental Hematology, OE 6960, Project: Targeting HIV Integration sites for long term remission and cure. Final exam June 2020. Muhammad Faisal PAKISTAN Supervisor: Prof. Dr.
Björn Zorn (2012) MPI for Chemical Energy Conversion, Mülheim Dr. Giulia Falorsi (2016) PhD at Universita’ degli Studi Di Siena, Italy Dr. Dmitry Soloviov (2016) Joint Institute for Nuclear Research, Dubna [...] Hannover, Germany Dr. Johannes Greve (2018-2021 Dr. rer. nat. in the Manstein group) Group leader, Institute for Biophysical Chemistry, MHH, Hannover, Germany Postdoctoral Research Assistants Postdoctoral Research [...] at the Max Planck Institute of Biochemistry, Munich, Germany Prof. Dr. Matthias Preller (2009-2012 Dr. rer. nat. in the Manstein group) Professor of Structural Bioinformatics, Centre for Structural Systems
asked by this panel. For case reports: The Joanna Briggs Institute Critical Appraisal Tool for case reports For case series: The Joanna Briggs Institute Critical Appraisal Tool for case series Tools will [...] / RATIONALE In 2013 the AAN consensus criteria for diagnosis of PML were published. This was a landmark achievement that established two approaches for diagnosis: the first based on characteristic hi [...] of JCV-related disease. Further, the development of robust pharmacovigilance programs for patients at highest risk for PML have taught to detect the earliest, even preclinical stages of disease. Taken together
Unit, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig MPI Germany Massachusetts General Hospital, Harvard Medical School Harvard-MGH USA Rensselaer Polytechnic Institute RPI USA Toure [...] (Interdisciplinary training network for Tourette Syndrome; structuring European Training capacities for neurodevelopmental disorders) As president of the European Society for the Study of Tourette Syndrome [...] limit for participation, i.e. adult "children" of any age (even >18 years) can participate, provided that both parents are willing to participate in the study, too. Contact for participation and for further
die ärztliche Tätigkeit: ethische Aspekte Referentin: Prof. Dr. Dr. Sabine Salloch, Leiterin des Instituts für Ethik, Geschichte und Philosophie der Medizin, MHH 26. Mai 2021 – 17:00: Robotik in der Medizin [...] Petra Verdonk: Inklusion in der Medizinischen Ausbildung (auf Englisch) Markus Ahlers (Doktorand, Institut für Philosophie, Leibniz Universität Hannover): Bias in der Datenverarbeitung 2020 26. August 2020 [...] Universitätsklinikum Essen, ehem. Präsidentin der bvmd Dr. Marianne Behrends, Peter L. Reichertz Institut für Med. Informatik der MHH und der TU Braunschweig & Prof'in Dr. Sandra Steffens, Curriculumse
am K, Künnemann K, Krey T, Wiedemann A, Gerold G, Grassl GA. Human tetraspanin CD81 facilitates invasion of Salmonella enterica into human epithelial cells. Virulence. 2024; 15(1):2399792 Asare Y, Simsekyilmaz [...] Kenney SP, Winklhofer KF, Behrendt P, Wedemeyer H, Steinmann E, Todt D. Genetic determinants of host- and virus-derived insertions for hepatitis E virus replication. Nat Commun.2024; 15(1):4855. Ye Z, Tan [...] Review Naderi Ramezan Abad R. Characterization of the inhibitory properties of Ruminococcus bromii for Clostridioides difficile infections. Leibniz Universität Hannover. 2024. MSc-Arbeit Oelschlegel AM
telle Ethik (Prof. Dr. C. Woopen) , Institut für Geschichte und Ethik der Medizin, Uniklinik Köln und (von 12/2013 bis 08/2016) Geschäftsstelle, Cologne Center for Ethics, Rights, Economics and Social [...] 09/2015 PostDoc-Forschungsaufenthalt MESH(Medicine, Ethics, Society and History)-Forschungsgruppe Institute of Applied Health Research, Department of Medical and Dental Sciences, University of Birmingham [...] unbefristeter Anstellung Leitung Arbeitsgruppe "Forschungsethik und medizinethische Methodologie" Institut für Ethik, Geschichte und Philosophie der Medizin, Medizinische Hochschule Hannover 01/2011 bis
Biofilms and Microbiomes. 2020. Publisher's page Heparin Anticoagulant for Human Bone Marrow Does Not Influence In Vitro Performance of Human Mesenchymal Stromal Cells. Roger, Yvonne, Burmeister, Laura, Hamm [...] Claudia, Claus, Peter; Hell, Anna K.. Human Molecular Genetics. 2020. Publisher's page The Long Non-coding RNA Cyrano Is Dispensable for Pluripotency of Murine and Human Pluripotent Stem Cells Hunkler, Hannah [...] Joachim; Chemnitz, Jan. PLOS ONE. 2024. Publisher's page Transient stabilization of human cardiovascular progenitor cells from human pluripotent stem cells in vitro reflects stage-specific heart development in
neurotoxins for novel medical applications: screening for light chain variants that cleave human SNAP23" Gebäude I 3, Ebene 01, R.-Nr. 2020, 12.00 Uhr 18.01.2013 Alessandro Provenzani, Ph.D. Centre for Integrative [...] Jacobs "Cellular Crosstalk of Human Natural Killer (NK) Cells " Gebäude I 3, Ebene 01, R.-Nr. 2020, 12.00 Uhr 27.05.2016 Dr. Stefan Sikorra "i) Re-engineering of BoNT/A for human SNAP-23 ii) Characterization [...] "Extended Botulinum Neurotoxin for Treatment of Chronic Pain" Gebäude I3, Ebene 01, Raum 2020 Beginn: 12:00 Uhr 14.06.2024 Khadija Aichane „Engineering the adenovirus E3/49K protein for potential therapeutic